Ascendis Pharma A/S
ASND- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001612042
In the last 90 days, Ascendis Pharma A/S insiders filed 1 open-market purchase and 2 sales; 313 institutions reported holding it in 13F filings for Q2 2026, worth $17.8B in total; no superinvestor holds it.
Q2 2023 vs. Q1 2023
How the institutions holding Ascendis Pharma A/S changed between Q1 2023 and Q2 2023.
All holders in Q2 2023All holders in Q1 2023
| Measure | Q1 2023 | Q2 2023 | Change |
|---|---|---|---|
| Holders | 164 | 158 | −6 |
| Shares | 61.0M | 61.0M | +31.6K (+0.1%) |
| Value | $6.54B | $5.45B | −$1.09B (−16.7%) |
New holders (27)
Institutions that held Ascendis Pharma A/S at the end of Q2 2023 but not at the end of Q1 2023.
Sold out (33)
Institutions that held Ascendis Pharma A/S at the end of Q1 2023 and filed for Q2 2023 without it.